Fingerpaint Group Acquires The MYND Group
Deal is expected to boost company’s market access capabilities.
Fingerpaint Group, an integrated collective of healthcare companies that provide commercialization solutions that span the entire product life cycle, is strengthening its market access offering with the acquisition of The MYND Group, a full-service strategic market access marketing company that works in the pharma and biologics spaces.
The company joins Fingerpaint Group's specialty services offerings that include medical and scientific communications, market access, and naming and branding capabilities.
"The MYND Group brings extensive market access strategy, research, and launch experience across multiple categories, including in the growing vaccine category," notes Bill McEllen, Fingerpaint Group’s global president. "This is our second market access acquisition in the last 3 years and is part of our continued commitment to evolving our market access capabilities to match the expectations and needs of the industry."
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.
